Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Jynneos Market CAGR Analysis And Future Market Development
The expansion observed during the historical timeframe is linked to worldwide campaigns aimed at wiping out smallpox, previous occurrences of monkeypox outbreaks, the creation of more secure vaccinia-based systems, government-led readiness measures, and public health vaccination programs.
Growth during the forecast period is expected to be driven by heightened risks from zoonotic diseases, the enlargement of national vaccine stockpiles, increased financial support for biodefense initiatives, enhanced worldwide monitoring networks, and the broadening of adult vaccination campaigns. Key developments shaping this period encompass a greater emphasis on preventing newly emerging infectious diseases, wider adoption of non-replicating vaccine platforms, an expansion of publicly funded immunization efforts, a surge in the strategic reserve of critical vaccines, and growing public understanding of illnesses transmitted from animals to humans.
Download A Free Sample Report For Comprehensive Market Insights:
Jynneos Market Demand Drivers: What Is Fueling Industry Growth?
The growing number of monkeypox infections is anticipated to propel the Jynneos market forward. Monkeypox is a viral illness triggered by the monkeypox virus, a member of the orthopoxvirus family. Cases of monkeypox are on the rise due to increased international travel and heightened contact between wildlife and humans, which allows infectious agents to spread quickly and turn localized outbreaks into larger events. Jynneos proves valuable for monkeypox cases by effectively preventing the virus in high-risk individuals and providing a safer option for those with compromised immune systems when compared to conventional smallpox vaccines. For example, as reported in September 2024 by the European Centre for Disease Prevention and Control—a government agency based in Europe—more than 100,000 confirmed cases of pox caused by monkeypox virus (MPXV) clades I and II, including over 200 deaths, were documented across over 120 countries worldwide between January 2022 and July 2024. Consequently, the surge in monkeypox cases is fueling expansion in the Jynneos market.
Jynneos Market Driver: Development Of Combined Vaccines To Enhance Public Health Preparedness
Major players in the Jynneos market are concentrating on creating combined vaccines aimed at tackling multiple diseases simultaneously. Combined vaccines are immunizations that offer protection against several illnesses with a single shot, thereby minimizing the number of injections needed for complete immunization. In August 2024, for instance, Bavarian Nordic A/S, a biotechnology firm headquartered in Denmark, announced that Singapore’s Health Sciences Authority (HSA) had granted approval for JYNNEOS (MVA-BN) as a preventive measure against smallpox and pox in adults aged 18 and older deemed at high risk for these infections. JYNNEOS (MVA-BN) is a non-replicating vaccine crafted to provide a safer option for various individuals, including those who are immunocompromised. Its development was aimed at improving public health readiness and addressing new infectious disease threats.
Jynneos Market Categorization By Product Type And Application
The jynneos market covered in this report is segmented –
1) By Indication: Prevention of Monkeypox, Prevention of Smallpox
2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution
3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations
4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers
Jynneos Market Company Landscape And Strategic Competition
Major companies operating in the jynneos market are Bavarian Nordic A/S
Access The Complete Jynneos Market Report:
Jynneos Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the jynneos market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model